Unknown PHASE3 INTERVENTIONAL 2-arm NCT02323620

Impact of Intracoronary Injection of Autologous BMMC for LV Contractility and Remodeling in Patients With STEMI (RACE-STEMI)

The Impact of Repeated Intracoronary Injection of Autologous Bone-marrow Derived Mononuclear Cells for Left Ventricle Contractility and Remodeling in Patients With STEMI.Prospective Randomized Study.

Sponsor: American Heart of Poland

Conditions Heart Failure Myocardial Infarction

Interventions Intracoronary infusion of BM-MC

Updated 7 times since 2017 Last updated: Jan 20, 2019 Started: Mar 31, 2019 Primary completion: Jul 31, 2022 Completion: Dec 31, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Heart Failure and Myocardial Infarction and is currently ongoing. American Heart of Poland leads this study, which shows 7 recorded versions since 2019 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Feb 2023 — Jul 2024 [monthly]

Unknown Status PHASE3

Status: Not Yet Recruiting → Unknown Status
Jan 2021 — Feb 2023 [monthly]

Not Yet Recruiting PHASE3
Feb 2019 — Jan 2021 [monthly]

Not Yet Recruiting PHASE3

Status: Unknown Status → Not Yet Recruiting

▶ Show 2 earlier versions

Jan 2019 — Feb 2019 [monthly]

Unknown Status PHASE3

Status: Not Yet Recruiting → Unknown Status
Jan 2017 — Jan 2019 [monthly]

Not Yet Recruiting PHASE3

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

American Heart of Poland

Data source: American Heart of Poland

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ustroń, Poland